This page is part of the Electronic Medicinal Product Information (ePI) FHIR Implementation Guide (v1.0.0: STU1) based on FHIR v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
DrugX 75 mg tablets
acetaminophen
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
status: Active
Domain: Human use
Combined pharmaceutical dose form:
Legal Status of Supply: Medicinal product subject to medical prescription
Authorisation 1 of 1
Auth id: authorization75mgRegion:
Type: Marketing Authorization
Holder (Organization): acme inc (http://example.org/sid/org#ORG1)
Status: Active (2015-02-07T13:28:17Z)
Package 1 of 1
Description:
Marketing Status: activeContained Quantity:
Package: 28 Blister [PolyVinyl Chloride]
Administrable Product (1 of 1)
Dose form: Tablet
Presentation unit: Tablet
Contents (Manuf. Items):Dose form: Tablet
Presentation unit: Tablet
Manufactured Dose Form: Tablet
Ingredients:Status: Active
Role: Active
Substance: acetaminophen
Status: Active
Role: Excipient
Substance: Silicon dioxide
Status: Active
Role: Excipient
Substance: Carnauba wax
Status: Active
Role: Excipient
Substance: Croscarmellose sodium
Status: Active
Role: Excipient
Substance: Hypromellose
Status: Active
Role: Excipient
Substance: Lactose Monohydrate
Status: Active
Role: Excipient
Substance: Macrogol 3000
Status: Active
Role: Excipient
Substance: Magnesium stearate
Status: Active
Role: Excipient
Substance: Microcrystalline cellulose
Status: Active
Role: Excipient
Substance: Titanium Dioxide
Clinical Information
Contraindication: Gastrointestinal disorders
Indication: Psoriasis
Interaction: METHOTREXATE
Undesirable Effect: Dysergia
Warning: Symptomatic hypotension, especially after the first dose, may occur in patients.